Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Intervalo de año de publicación
1.
Expert Rev Anti Infect Ther ; 12(5): 549-54, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24689705

RESUMEN

In the era of multidrug resistance, it is critical to utilize antibiotics in an appropriate manner and to identify new treatments or revisit the use of 'forgotten' drugs. Because urinary tract infections (UTIs) are common, particularly in an increasing elderly population, the 'forgotten' drug, methenamine, may become important as a preventive therapy for recurrent UTIs. Methenamine, a urinary antibacterial agent, can be used as methenamine hippurate or methenamine mandelate preparations and is United States Food and Drug Administration-approved. This article discusses the place of preventive therapy for recurrent UTIs, chemistry, mechanism of action, pharmacology, clinical uses, dosage, adverse reactions and safety, and drug interactions of methenamine. Because of its unique antiseptic property, the authors suggest that methenamine should be considered when more commonly used antibiotics fail to suppress recurrent UTIs.


Asunto(s)
Antiinfecciosos Urinarios/uso terapéutico , Infecciones por Bacterias Gramnegativas/tratamiento farmacológico , Infecciones por Bacterias Grampositivas/tratamiento farmacológico , Hipuratos/uso terapéutico , Ácidos Mandélicos/uso terapéutico , Metenamina/análogos & derivados , Infecciones Urinarias/tratamiento farmacológico , Antiinfecciosos Urinarios/efectos adversos , Antiinfecciosos Urinarios/farmacocinética , Esquema de Medicación , Cálculo de Dosificación de Drogas , Farmacorresistencia Bacteriana Múltiple , Bacterias Gramnegativas/efectos de los fármacos , Bacterias Gramnegativas/fisiología , Infecciones por Bacterias Gramnegativas/microbiología , Bacterias Grampositivas/efectos de los fármacos , Bacterias Grampositivas/fisiología , Infecciones por Bacterias Grampositivas/microbiología , Hipuratos/efectos adversos , Hipuratos/farmacocinética , Humanos , Ácidos Mandélicos/efectos adversos , Ácidos Mandélicos/farmacocinética , Metenamina/efectos adversos , Metenamina/farmacocinética , Metenamina/uso terapéutico , Recurrencia , Infecciones Urinarias/microbiología
2.
Anticancer Res ; 22(6B): 3765-76, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12552990

RESUMEN

Dimethylsilane tetramines are structural analogues of spermine with a (CH3)2 Si-group incorporated into the central carbon chain. They have potential as anticancer drugs. Their cytotoxic effect was considered to rely mainly on their polyamine antagonist property. In order to obtain new ideas about cellular mechanisms, which are potential targets of the dimethylsilane polyamines, the effects of these compounds on some basic cell functions, such as protein and DNA synthesis, and calmodulin antagonism were studied. In addition, their mode of accumulation in cells was investigated. It became evident that the intracellular accumulation of dimethylsilane polyamines is almost exclusively achieved via the polyamine transport system. However, the exchange of a part of the intracellular natural polyamines against dimethylsilane polyamines has only a small effect on polyamine uptake. Binding to the endoplasmic reticulum and inhibition of protein synthesis are presumably important for the cytotoxic action of bis(11-amino-4,8-diazaundecyl)dimethylsilane, a hexamine, but seem of no importance for the tetramines. Calmodulin antagonism, however, is likely to contribute to their cytotoxic effect.


Asunto(s)
Antineoplásicos/farmacología , Antineoplásicos/farmacocinética , Calmodulina/análogos & derivados , Poliaminas/farmacología , Poliaminas/farmacocinética , Silanos/farmacología , Silanos/farmacocinética , Animales , Células CHO/efectos de los fármacos , Células CHO/metabolismo , Calmodulina/metabolismo , Agregación Celular/efectos de los fármacos , Ciclo Celular/efectos de los fármacos , División Celular/efectos de los fármacos , Cricetinae , ADN de Neoplasias/metabolismo , Ensayos de Selección de Medicamentos Antitumorales , Leucina/antagonistas & inhibidores , Leucina/metabolismo , Leucemia L1210/tratamiento farmacológico , Leucemia L1210/metabolismo , Metenamina/farmacocinética , Metenamina/farmacología , Ratones , Microsomas Hepáticos/efectos de los fármacos , Oxidorreductasas actuantes sobre Donantes de Grupo CH-NH/antagonistas & inhibidores , Oxidorreductasas actuantes sobre Donantes de Grupo CH-NH/metabolismo , Ratas , Espermidina/antagonistas & inhibidores , Espermidina/farmacocinética , Timidina/antagonistas & inhibidores , Timidina/metabolismo , Poliamino Oxidasa
3.
J Endod ; 21(3): 122-7, 1995 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-7561653

RESUMEN

Four root canal sealers (AH-26, Roth 811, CRCS, and Sealapex) were tested for tissue biocompatibility in rat connective tissue. Each sealer was placed in Teflon tubes and implanted subcutaneously in Wistar-Furth rats. The implants were removed after 7, 14, and 21 days, fixed, and histologically prepared for microscopical evaluation. Brain, liver, kidneys, and uterus were removed from the animals killed at the first experimental period (7 days) and analyzed for zinc and calcium concentration by flame atomic absorption spectrophotometry. In total, 100 specimens were examined. At the seventh day, the most irritant material was seen to be AH-26, but this inflammatory reaction decreased with time. Roth 811 and Sealapex caused moderate-to-severe inflammatory reaction, whereas CRCS caused mild to moderate. CRCS and Roth 811 induced redistribution of zinc, whereas AH-26 induced changes in calcium content in some organs.


Asunto(s)
Tejido Conectivo/efectos de los fármacos , Resinas Epoxi , Materiales de Obturación del Conducto Radicular/efectos adversos , Salicilatos , Animales , Materiales Biocompatibles/efectos adversos , Materiales Biocompatibles/farmacocinética , Bismuto/efectos adversos , Bismuto/farmacocinética , Química Encefálica , Calcio/análisis , Hidróxido de Calcio/efectos adversos , Hidróxido de Calcio/farmacocinética , Tejido Conectivo/metabolismo , Combinación de Medicamentos , Femenino , Reacción a Cuerpo Extraño/etiología , Riñón/química , Hígado/química , Metenamina/efectos adversos , Metenamina/farmacocinética , Ratas , Ratas Wistar , Materiales de Obturación del Conducto Radicular/farmacocinética , Plata/efectos adversos , Plata/farmacocinética , Distribución Tisular , Titanio/efectos adversos , Titanio/farmacocinética , Útero/química , Zinc/análisis , Óxido de Zinc/efectos adversos , Óxido de Zinc/farmacocinética , Cemento de Óxido de Zinc-Eugenol/efectos adversos , Cemento de Óxido de Zinc-Eugenol/farmacocinética
6.
J Pharm Sci ; 70(9): 1017-24, 1981 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-6101145

RESUMEN

Dissolution profiles were determined for nine methenamine, 14 nitrofurantoin, and six chlorothiazide dosage forms using a dissolution simulator. Various in vivo-in vitro correlations were examined. The best correlation for methenamine was between the maximum urinary excretion rate and the time for 15% dissolution. A good correlation for the 50-mg nitrofurantoin tablets was also found between cumulative percent of drug excreted in 12 hr and the percent dissolved in 1 hr. There were no significant correlations for the 100-mg nitrofurantoin dosage forms. Good correlations were also observed for the 250- and 500-mg chlorothiazide tablets between the percent of drug dissolved in 1 min or the time for 15% dissolution and the maximum excretion rate.


Asunto(s)
Clorotiazida/farmacocinética , Metenamina/farmacocinética , Nitrofurantoína/farmacocinética , Absorción , Clorotiazida/química , Metenamina/química , Nitrofurantoína/química , Solubilidad , Comprimidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA